Pillstats
Rx only · Tablet, Film Coated · Oral

Lorlatinib

Brands: Lorbrena · Lorlatinib

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01ED05
RxCUI (US)2103164
US makers2 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2354697049382025 Q12025 Q22025 Q32025 Q42026 Q1
810
Rx · 2026 Q1
39K
Units dispensed
+27%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown3SUPPLYING
U.S. Pharmaceuticalsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 15, 2026
    RESOLVEDShortage resolved: Lorlatinib Tablet (Pfizer Inc.)

    Lorlatinib Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Oncology.

  • Jun 15, 2026
    SHORTAGEDrug shortage: Lorlatinib Tablet (Pfizer Inc.)

    Lorlatinib Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Oncology.